Bio-Techne

131 articles with Bio-Techne

• Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development

  8/8/2018

  Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies.

• Bio-Techne Releases Fourth Quarter Fiscal 2018 Results

  8/7/2018

  Bio-Techne Corporation reported its financial results for the fourth quarter ended June 30, 2018.

• Bio-Techne Declares Dividend Payable August 31, 2018

  8/7/2018

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2018.

• Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc.

  8/1/2018

  Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Exosome Diagnostics, Inc.

• Bio-Techne Introduces New Member of the Simple Western™ Family, with IR/NIR Detection Capabilities

  7/24/2018

  Bio-Techne again disrupts protein analysis technology with the introduction of the newest member of their ProteinSimple-branded Simple Western family, Jess.

• Bio-Techne To Host Conference Call On August 7, 2018 To Announce Fourth Quarter 2018 Financial Results

  7/12/2018

  Bio-Techne Corporation announced that management will host a conference call on Tuesday, August 7, 2018 at 8:00 a.m. CDT to review fourth quarter 2018 financial results.

• Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

  7/10/2018

  Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results

• Bio-Techne Expands RNAscope® Assay Services Portfolio to Shorten Development Times and Save Costs

  6/26/2018

  Validated tissue bank and pre-collected immuno-oncology datasets speed up investigative research projects through to clinical development...

• Bio-Techne To Acquire Quad Technologies

  6/7/2018

  The transaction is expected to close in early July and to be financed through available cash on hand.

• Bio-Techne To Present At The William Blair 38th Annual Growth Stock Conference

  6/4/2018

  Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the William Blair 38th Annual Growth Stock Conference.

• Bio-Techne Releases Third Quarter Fiscal 2018 Results

  5/2/2018

  Bio-Techne Corporation reported its financial results for the third quarter ended March 31, 2018.

• Bio-Techne Declares Dividend of $0.32 Per Share

  5/2/2018

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2018.

• Bio-Techne Leads the Way in Scientific Support for Autophagy Research

  4/26/2018

  Bio-Techne has a leading role supporting autophagy research.

• Bio-Techne Expands RNAscope® ISH Automation - Facilitating Drug Discovery and Development

  3/21/2018

  Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays.

• Bio-Techne Launches MimEX™ GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract

  3/14/2018

  Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface.

• Bio-Techne Releases Second Quarter Fiscal 2018 Results

  2/6/2018

  Bio-Techne today reported its financial results for the second quarter ended December 31, 2017.

• Bio-Techne's Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms

  1/31/2018

  The investment underscores BioAgilytix's commitment to effectively addressing customers' evolving biomarker assay needs.

• Bio-Techne to Host Conference Call on February 6, 2018 to Announce Second Quarter 2018 Financial Results

  1/18/2018

  Bio-Techne today announced that management will host a conference call on February 6, 2018, at 8:00 a.m. CST to review second quarter 2018 financial results.

• Advanced Immunolabeling Reagents and Tools From Vector Laboratories Now from Bio-Techne

  1/15/2018

  Several reagents from Vector Laboratories are currently available at novusbio.com for distribution within the continental U.S.

• Bio-Techne Acquires Atlanta Biologicals

  1/2/2018

  Bio-Techne announced today that it has acquired all of the stock of Atlanta Biologicals and its affiliated company, Scientific Ventures.